IDH2 and acute myeloid leukemia: Mutations in IDH genes are present in 18–22% of AML and lead to accumulation of the oncometabolite R-2-hydroxyglutarate (2-HG), which ultimately creates epigenetic alterations and differentiation arrest of AML blasts.